Real-time enrollment status for this limbal stem cell deficiency clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:08 PM UTC
| NCT Number | NCT06452316 |
| Recruiting Status | Recruiting |
| Condition | Limbal Stem Cell Deficiency |
| Phase | PHASE1 |
| Target Enrollment | 75 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Claris Biotherapeutics, Inc. |
| Last Updated on CT.gov | August 13, 2026 (2 weeks ago) |
As of August 28, 2026: Clinical trial NCT06452316 is currently recruiting participants. This phase1 study for limbal stem cell deficiency is actively seeking new participants at 6 locations across the United States. The study is sponsored by Claris Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06452316 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06452316 was last updated 2 weeks ago (August 13, 2026). HelloStudys verifies this status automatically.